A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis
- Conditions
- Unrecognized Condition
- Registration Number
- NCT03477071
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
Stenosis of the renal graft arteries occurs in 1 to 26% of cases and can damage the graft. Endovascular treatment is first-line treatment. The main objective of this study is to identify the predictive factors of failure of peri-anastomotic.
- Detailed Description
The aim of this study was to evaluate the post-operative outcomes following endovascular treatment of TRAS (Transplant Renal Artery Stenosis).
This retrospective, monocentric study included patients with peri-anastomotic stenosis of the renal graft from 2000 to 2017. The stenosis is defined by a reduction of at least 50% of the arterial diameter during arteriography. Technical success was defined as residual stenosis less than 30% of the arterial diameter after the procedure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1323
- All patients who had a renal transplant from brain-dead donors or from living donors
- All patients who had a Transplant Renal Artery Stenosis
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The technical success rate of endovascular treatment 30 days The stenosis is defined by a reduction of at least 50% of the arterial diameter during arteriography. Technical success was defined as residual stenosis less than 30% of the arterial diameter after the procedure
- Secondary Outcome Measures
Name Time Method Mortality rate 30 days All death are recorded to identify the mortality rate
Morbidity rate 30 days Morbidity rate is defined as the development of post-operative complications. Minor and major complications are recorded, corresponding to Clavien Dindo classification